Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
BMC Pregnancy and Childbirth
Published in: BMC Pregnancy and Childbirth 1/2017

Open Access 01-12-2017 | Research article

Barriers and facilitators related to the uptake of four strategies to prevent neonatal early-onset group B haemolytic streptococcus disease: a qualitative study

Authors: Diny G. E. Kolkman, Margot A. H. Fleuren, Maurice G. A. J. Wouters, Christianne J. M. de Groot, Marlies E. B. Rijnders

Published in: BMC Pregnancy and Childbirth | Issue 1/2017

Login to get access

Abstract

Background

Actions to prevent early onset disease in neonates are based on different strategies including administering antibiotic prophylaxis during labour in case of 1) maternal GBS colonisation (screening strategy), 2) identified risk factors (risk-based strategy) or 3) a combination of these two conditions (maternal GBS colonisation and identified risk factors: combination strategy and the Dutch guideline). Low adherence to guidelines preventing EOGBS has been reported. Each strategy has drawbacks and clinical outcomes are affected by care providers’ and women’s adherence. The actual impact of any preventive strategy is the product of efficacy of the strategy and the level of implementation. In order to reduce neonatal death due to EOGBS by developing the optimal guideline, we analysed barriers and facilitators of current used strategies.

Methods

Focus group and personal interviews with care providers and women were performed. Impeding and enhancing factors in adherence to the preventive strategies were discussed and scored using the Measurement Instrument for Determinants of Innovations (MIDI) and analysed by two independent researchers.

Results

Overall, care providers identified 3.6 times more factors that would impede (n = 116) rather than facilitate (n = 32) adherence to the preventive strategies. 28% facilitative factors were reported in relation to the combination strategy and 86% impeding factors in relation to the Dutch guideline. The most preferred strategy was the combination strategy by 74% of the care providers and by 86% of the women.

Discussion

We obtained a detailed understanding of factors that influence adherence to preventive strategies.
This insight can be used to develop implementation activities to improve the uptake of new strategies.

Trial registration

The trial is registered in the Dutch Trial Register NTR3965.
Appendix
Available only for authorised users
Literature
1.
Bekker V, Bijlsma MW, van de Beek D, Kuijpers TW, van der Ende A. Incidence of invasive group B streptococcal disease and pathogen genotype distribution in newborn babies in the Netherlands over 25 years: a nationwide surveillance study. Lancet Infect Dis. 2014;14(11). doi:10.​1016/​S1473-3099(14)70919-3.
2.
Edmond KM, Kortsalioudaki C, Scott S, et al. Group B streptococcal disease in infants aged younger than 3 months: Systematic review and meta-analysis. Lancet. 2012;379(9815). doi:10.​1016/​S0140-6736(11)61651-6.
3.
Trijbels-Smeulders M, Gerards LJ, M PC, et al. Epidemiology of neonatal group B streptococcal disease in The Netherlands 1997-98. Paediatr Perinat Epidemiol. 2002;16(4). doi:10.​1136/​adc.​2005.​088799.
4.
Benitz WE, Gould JB, Druzin ML. Antimicrobial prevention of early-onset group B streptococcal sepsis: estimates of risk reduction based on a critical literature review. Pediatrics. 1999;103(6). doi:10.​1542/​peds.​103.​6.​e78.
5.
6.
7.
8.
Trijbels-Smeulders M, de Jonge GA, Pasker-de Jong PCM, et al. Epidemiology of neonatal group B streptococcal disease in the Netherlands before and after introduction of guidelines for prevention. Arch Dis Child Fetal Neonatal Ed. 2007;92(4). doi:10.​1136/​adc.​2005.​088799.
9.
10.
Stoll BJ, Hansen NI, Sánchez PJ, et al. Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics. 2011;127(5). doi:10.​1542/​peds.​2010-2217.
11.
12.
Vergnano S, Embleton N, Collinson A, Menson E, Russell AB, Heath P. Missed opportunities for preventing group B streptococcus infection. Arch Dis Child Fetal Neonatal Ed. 2010;95(1). doi:10.​1136/​adc.​2009.​160333.
13.
14.
Van Den Akker-Van Marle ME, Rijnders MEB, Van Dommelen P, et al. Cost-effectiveness of different treatment strategies with intrapartum antibiotic prophylaxis to prevent early-onset group B streptococcal disease. BJOG. 2005;112(6). doi:10.​1111/​j.​1471-0528.​2005.​00555.​x.
15.
Eastwood KA, Craig S, Sidhu H, et al. Prevention of early-onset Group B Streptococcal disease - the Northern Ireland experience. BJOG. 2015;122(3). doi:10.​1111/​1471-0528.​12841.
16.
Kunze M, Zumstein K, Markfeld-Erol F, et al. Comparison of pre- and intrapartum screening of group B streptococci and adherence to screening guidelines: a cohort study. Eur J Pediatr. 2015;Jun(174(6)). doi:10.​1007/​s00431-015-2548-y.
17.
Grol R, Wensing M, Eccles M. Lmproving Patient Care: The Implementation of Change in Clinical Practice. Edinburgh: Elsevier; 2005.
18.
Fleuren M, Wiefferink K, Paulussen T. Determinants of innovation within health care organizations: literature review and Delphi study. Int J Qual Health Care. 2004;16(2). doi:10.​1093/​intqhc/​mzh030.
19.
20.
Bartholomew LK, Parcel GS, Kok G, Gottlieb NH. Planning Health Promotion Programs: An Intervention Mapping Approach. 3rd ed. San Franscisco: Jossey Bass; 2011.
21.
Fleuren MAH, Paulussen TGWM, Dommelen PVAN, Van Buuren S. Towards a measurement instrument for determinants of innovations. Int J Qual Heal Care. 2014;26(5):501–510.
22.
Kolkman DGE, Rijnders MEB, Wouters MGAJ, et al. Implementation of a cost-effective strategy to prevent neonatal early-onset group B haemolytic streptococcus disease in the Netherlands. BMC Pregnancy Childbirth. 2013;13(1). doi:10.​1186/​1471-2393-13-155.
23.
College voor Zorgverzekeringen. Obstetric Manual 2003 Verloskundig Vademecum 2003 Eindrapport van de Commissie Verloskunde. 1st ed. Diemen: College voor Zorgverzekeringen; 2003.
Metadata
Title
Barriers and facilitators related to the uptake of four strategies to prevent neonatal early-onset group B haemolytic streptococcus disease: a qualitative study
Authors
Diny G. E. Kolkman
Margot A. H. Fleuren
Maurice G. A. J. Wouters
Christianne J. M. de Groot
Marlies E. B. Rijnders
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Pregnancy and Childbirth / Issue 1/2017
Electronic ISSN: 1471-2393
DOI
https://doi.org/10.1186/s12884-017-1314-8

Other articles of this Issue 1/2017

BMC Pregnancy and Childbirth 1/2017 Go to the issue

Research article

Quality and uptake of antenatal and postnatal care in Haiti

Research article

Use of cervicovaginal PAMG-1 protein as a predictor of delivery within seven days in pregnancies at risk of premature birth

Research article

Quality of antenatal care services and completion of four or more antenatal care visits in Ethiopia: a finding based on a demographic and health survey

Research article

Maternal iodine status during lactation and infant weight and length in Henan Province, China

Research article

Pregnant women’s preferences for and concerns about preterm birth prevention: a cross-sectional survey

Research article

Manifestations and drivers of mistreatment of women during childbirth in Kenya: implications for measurement and developing interventions